MeiraGTx Holdings (MGTX) Profit After Tax (2017 - 2025)
MeiraGTx Holdings posted quarterly Profit After Tax of $15.1 million for Q4 2025, up 138.3% year-on-year from $6.3 million in Q4 2024, and up 129.87% on a QoQ basis from -$50.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Profit After Tax data on file, last reported at $15.1 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax rose 138.3% year-over-year to $15.1 million; the trailing twelve-month figure through Dec 2025 stood at -$114.2 million (up 22.73% YoY), and the FY2025 full-year result was -$114.2 million, up 22.73% from the prior year.
- Profit After Tax for Q4 2025 stood at $15.1 million, up from -$50.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at $20.2 million in Q4 2023 and bottomed at -$50.5 million in Q3 2025.
- The 5-year median for Profit After Tax is -$30.7 million (2022), against an average of -$27.8 million.
- The widest annual swing landed in 2021, when Profit After Tax sank 303.37%; it then jumped 174.01% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$9.9 million in 2021, then tumbled by 175.55% to -$27.3 million in 2022, then surged by 174.01% to $20.2 million in 2023, then sank by 294.9% to -$39.4 million in 2024, then soared by 138.3% to $15.1 million in 2025.
- The last three Profit After Tax figures came in at $15.1 million (Q4 2025), -$50.5 million (Q3 2025), and -$38.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 15.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.09 Mn |
| Sep 30, 2025 | -50.51 Mn |
| Jun 30, 2025 | -38.80 Mn |
| Mar 31, 2025 | -39.98 Mn |
| Dec 31, 2024 | -39.40 Mn |
| Sep 30, 2024 | -39.33 Mn |
| Jun 30, 2024 | -48.62 Mn |
| Mar 31, 2024 | -20.44 Mn |
| Dec 31, 2023 | 20.22 Mn |
| Sep 30, 2023 | -44.30 Mn |
| Jun 30, 2023 | -29.58 Mn |
| Mar 31, 2023 | -30.36 Mn |
| Dec 31, 2022 | -27.31 Mn |
| Sep 30, 2022 | -37.28 Mn |
| Jun 30, 2022 | -33.97 Mn |
| Mar 31, 2022 | -31.05 Mn |
| Dec 31, 2021 | -9.91 Mn |
| Sep 30, 2021 | -25.95 Mn |
| Jun 30, 2021 | -20.09 Mn |
| Mar 31, 2021 | -23.62 Mn |
| Dec 31, 2020 | -10.46 Mn |
| Sep 30, 2020 | -6.43 Mn |
| Jun 30, 2020 | -25.42 Mn |
| Mar 31, 2020 | -15.68 Mn |
| Dec 31, 2019 | -5.48 Mn |
| Sep 30, 2019 | -10.46 Mn |
| Jun 30, 2019 | -20.82 Mn |
| Mar 31, 2019 | -17.98 Mn |
| Dec 31, 2018 | -21.06 Mn |
| Sep 30, 2018 | -15.42 Mn |
| Jun 30, 2018 | -29.98 Mn |
| Mar 31, 2018 | -16.40 Mn |
| Dec 31, 2017 | -8.60 Mn |
| Sep 30, 2017 | -8.44 Mn |
| Jun 30, 2017 | -7.18 Mn |